829 related articles for article (PubMed ID: 9329960)
1. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
Chuang HC; Lay JD; Hsieh WC; Su IJ
Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma.
Ohno T; Miyake N; Hada S; Hirose Y; Imura A; Hori T; Uchiyama T; Saiga T; Mizumoto T; Furukawa H
Cancer; 1998 May; 82(10):1963-72. PubMed ID: 9587131
[TBL] [Abstract][Full Text] [Related]
6. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
[TBL] [Abstract][Full Text] [Related]
7. MIP-1alpha expression in tissues from patients with hemophagocytic syndrome.
Teruya-Feldstein J; Setsuda J; Yao X; Kingma DW; Straus S; Tosato G; Jaffe ES
Lab Invest; 1999 Dec; 79(12):1583-90. PubMed ID: 10616208
[TBL] [Abstract][Full Text] [Related]
8. Epstein-barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome.
Lay JD; Chuang SE; Rowe M; Su IJ
J Biomed Sci; 2003; 10(1):146-55. PubMed ID: 12607539
[TBL] [Abstract][Full Text] [Related]
9. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.
Ohga S; Matsuzaki A; Nishizaki M; Nagashima T; Kai T; Suda M; Ueda K
Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):291-8. PubMed ID: 8328642
[TBL] [Abstract][Full Text] [Related]
11. IL-12 producing monocytes and IFN-gamma and TNF-alpha producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum.
Diouf I; Fievet N; Doucouré S; Ngom M; Andrieu M; Mathieu JF; Gaye A; Thiaw OT; Deloron P
J Reprod Immunol; 2007 Jun; 74(1-2):152-62. PubMed ID: 17194481
[TBL] [Abstract][Full Text] [Related]
12. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction.
Yang L; Aozasa K; Oshimi K; Takada K
Cancer Res; 2004 Aug; 64(15):5332-7. PubMed ID: 15289339
[TBL] [Abstract][Full Text] [Related]
14. Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome.
Sato S; Kawashima H; Oshiro H; Hasegawa D; Kashiwagi Y; Takekuma K; Hoshika A
J Clin Virol; 2004 Nov; 31(3):235-8. PubMed ID: 15465418
[TBL] [Abstract][Full Text] [Related]
15. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.
Gazzinelli RT; Eltoum I; Wynn TA; Sher A
J Immunol; 1993 Oct; 151(7):3672-81. PubMed ID: 7690809
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.
Su IJ; Chen RL; Lin DT; Lin KS; Chen CC
Am J Pathol; 1994 Jun; 144(6):1219-25. PubMed ID: 8203462
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra.
Tsukaguchi K; de Lange B; Boom WH
Cell Immunol; 1999 May; 194(1):12-20. PubMed ID: 10357876
[TBL] [Abstract][Full Text] [Related]
18. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
20. Adhesion of Epstein-Barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines.
Kanno H; Watabe D; Shimizu N; Sawai T
Clin Exp Immunol; 2008 Mar; 151(3):519-27. PubMed ID: 18190605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
